Michael Yu, MD
Urology · Centerville, OHNPI 1104816131
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Medtronic at 26.3% of the total. Reporting peaked in 2022 at $11,117 and has fallen 50.7% since, to $5,483 in 2025. Among urology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $145.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Coloplast$10K
- Axonics, Inc.$5K
- Teleflex LLC$4K
- Boston Scientific$3K
- Calyxo, Inc.$3K
- plus $6K from 29 others
What the payments were for
- Consulting fees$7,84018%
- Speaking & faculty fees$1,4603%
- Grants$7,25017%
- Travel & lodging$11,06926%
- Food & beverage$14,81335%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $11,163 |
| Coloplast | 32 | $9,956 |
| Axonics, Inc. | 44 | $4,713 |
| Teleflex LLC | 19 | $3,716 |
| Boston Scientific | 51 | $3,325 |
| Calyxo, Inc. | 22 | $3,281 |
| Procept Biorobotics Corporation | 23 | $2,350 |
| Neotract Inc. | 12 | $2,158 |
| Ferring Pharmaceuticals Inc. | 2 | $236 |
| Stryker | 2 | $214 |
| Lumenis, Inc | 3 | $182 |
| Myovant Sciences Inc. | 4 | $174 |
| Johnson & Johnson(2 entities) | 11 | $146 |
| Astellas Pharma US Inc | 11 | $139 |
| Bluewind Medical | 1 | $90 |
| Olympus America Inc. | 1 | $75 |
| Bayer | 6 | $71 |
| AstraZeneca | 2 | $61 |
| Rochester Medical Corporation | 2 | $55 |
| Tolmar Pharmaceuticals, Inc. | 3 | $47 |
| Laborie Medical Technologies Corp. | 2 | $43 |
| AbbVie | 2 | $33 |
| Sun Pharmaceutical Industries Inc. | 2 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $33 |
| Foundation Medicine, Inc. | 1 | $33 |
| Antares Pharma, Inc. | 2 | $29 |
| Abbott | 1 | $26 |
| Innovation Technologies Inc | 1 | $18 |
| Travere Therapeutics, Inc. | 2 | $17 |
| Cook Medical LLC | 1 | $17 |
| 180 Medical, Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Amgen | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Bard Access Systems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$7,480
- UroLift$4,270
- CVAC Aspiration System$2,920
- Axonics r-SNM System$2,554
- ALTAVIVA$1,672
- INTERSTIM$1,570
- Bulkamid$1,546
- AquaBeam Robotic System$1,234
- Axonics$1,053
- UroLift System$935
- GENERAL KIDNEY STONE DISEASE$871
- GENERAL BPH$760
- TITAN$480
- AQUABEAM SYSTEM$277
- 1588 HD 3 CHIP CAMERA$214
- GENERAL - THERAPIES$161
- Lumenis Pulse 120H$143
- ADSTILADRIN$140
- Coloplast TFL Drive$131
- Isiris aStent Removal Device$107
How this compares
$42,503 in reported general payments places this provider in the 90th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 27 | $25,511 |
| GemtesaVibegron | 19 | $19,045 |
| Potassium Citrate ErPotassium Citrate | 22 | $3,875 |
| Tamsulosin Hcl | 333 | $3,204 |
| Dutasteride | 46 | $1,850 |
| Trospium Chloride | 13 | $1,516 |
| Testosterone Cypionate | 25 | $1,208 |
| Silodosin | 13 | $1,010 |
| Ondansetron OdtOndansetron | 76 | $1,004 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 61 | $774 |
| Oxybutynin Chloride ErOxybutynin Chloride | 67 | $773 |
| Diclofenac Sodium | 123 | $674 |
| Finasteride | 53 | $642 |
| Ciprofloxacin Hcl | 105 | $585 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 130 | $507 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $139 | $25,51127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 485 urology providers in Ohio.
Other urology in Centerville
- Blake AndersonCenterville$47K
- Krishnanath GaitondeCenterville$34K
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
- Sandip VasavadaCleveland$263K
- Jihad KaoukCleveland$234K
- Benjamin MartinGahanna$205K
- Ruben OlivaresCleveland$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.